Reviewing Adagio Medical (NASDAQ:ADGM) & Anteris Technologies Global (NASDAQ:AVR)
by Danessa Lincoln · The Markets DailyAnteris Technologies Global (NASDAQ:AVR – Get Free Report) and Adagio Medical (NASDAQ:ADGM – Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership.
Valuation & Earnings
This table compares Anteris Technologies Global and Adagio Medical”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Anteris Technologies Global | $2.24 million | 338.19 | -$94.14 million | ($1.95) | -3.99 |
| Adagio Medical | $600,000.00 | 7.74 | -$25.08 million | ($1.48) | -0.14 |
Adagio Medical has lower revenue, but higher earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than Adagio Medical, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Anteris Technologies Global and Adagio Medical, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Anteris Technologies Global | 1 | 0 | 4 | 0 | 2.60 |
| Adagio Medical | 1 | 1 | 2 | 0 | 2.25 |
Anteris Technologies Global presently has a consensus price target of $16.00, suggesting a potential upside of 105.66%. Adagio Medical has a consensus price target of $3.50, suggesting a potential upside of 1,574.64%. Given Adagio Medical’s higher possible upside, analysts clearly believe Adagio Medical is more favorable than Anteris Technologies Global.
Profitability
This table compares Anteris Technologies Global and Adagio Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Anteris Technologies Global | -4,619.27% | -77.69% | -67.99% |
| Adagio Medical | N/A | -661.85% | -73.35% |
Risk & Volatility
Anteris Technologies Global has a beta of 1.8, indicating that its share price is 80% more volatile than the S&P 500. Comparatively, Adagio Medical has a beta of -0.09, indicating that its share price is 109% less volatile than the S&P 500.
Insider and Institutional Ownership
48.1% of Adagio Medical shares are held by institutional investors. 4.5% of Anteris Technologies Global shares are held by insiders. Comparatively, 7.8% of Adagio Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
About Anteris Technologies Global
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
About Adagio Medical
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.